Search filters

List of works by Eduardo Ramacciotti

A Comprehensive Overview of Direct Oral Anticoagulants for the Management of Venous Thromboembolism.

scientific article

A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil.

scientific article published on 18 January 2006

An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.

scientific article published on February 2011

Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model

scientific article published on 23 February 2017

Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups

scientific article published on 01 March 2013

Apixaban pharmacodynamic activity in umbilical cord, paediatric, and adult plasma

scientific article published on 24 May 2017

Apixaban: an Oral Direct Factor-Xa Inhibitor

scientific article published on February 17, 2012

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa

scientific article published on 01 January 2020

Betrixaban for VTE Prevention in the Medically Ill Population, the APEX Trial: Good News for This Needy Population?

scientific article published on 18 December 2016

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version

scientific article published on 01 January 2020

Comparative blood flow study of arteriovenous fistulae in canine femoral arteries: modified latero-lateral and end-lateral techniques

scientific article published on 01 March 2000

Concerns on generic enoxaparin use in acute coronary syndrome

scientific article published on October 2010

Contaminant in the recalled unfractionated heparin preparations: where is the problem?

scientific article published on 19 June 2008

Contaminants in heparins: are all facts known?

scientific article published on 01 June 2010

Contaminated heparin preparations, severe adverse events and the contact system

scientific article published on 01 October 2008

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?

scientific article published on 01 January 2019

Do galectins play a role in venous thrombosis? a review.

scientific article published on 02 December 2009

Drug-Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms

scientific article published on 01 January 2020

Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?

scientific article published on 22 September 2017

Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial

scientific article published on 10 December 2015

Edoxaban for Venous Thromboembolism Treatment-The New Kid on The Block for Latin America. A Practical Guide

scientific article published on 28 November 2018

Efficacy and Safety of a Biosimilar Versus Branded Enoxaparin in the Prevention of Venous Thromboembolism Following Major Abdominal Surgery: A Randomized, Prospective, Single-Blinded, Multicenter Clinical Trial

scientific article published on 18 July 2018

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

Enoxaparin Dosing After Discharge From US Hospitals in Patients With Total Knee Replacement

scientific article published on February 16, 2012

Enoxaparin Treatment Followed by Rivaroxaban for the Treatment of Acute Lower Limb Venous Thromboembolism: Initial Experience in a Single Center

scientific article published on 05 January 2016

Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis

scientific article published on May 17, 2011

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020

scientific article published on 01 January 2020

Generic versus branded enoxaparin in the prevention of venous thromboembolism following major abdominal surgery: report of an exploratory clinical trial

scientific article published on 23 September 2011

Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants

scientific article published on February 1, 2013

Latero-lateral femoro-femoral arteriovenous fistula: a new surgical approach for hemodialysis patients with no vascular access

scientific article published on 01 February 2011

Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

scientific article published in April 2009

Medical management of stable peripheral artery disease: the COMPASS trial. Perspectives from a vascular standpoint

scientific article published on 09 May 2018

Oral Rivaroxaban for the Treatment of Symptomatic Venous Thromboembolism in 400 Patients With Active Cancer: A Single-Center Experience

scientific article published in January 2016

P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

scientific article published on 4 December 2009

Pharmacological Prophylaxis for Venous Thromboembolism Among Hospitalized Patients With Acute Medical Illness: An Electronic Medical Records Study

scientific article

Proteomics of microparticles after deep venous thrombosis.

scientific article published on 13 February 2010

Rediscussing Anticoagulation in Distal Deep Venous Thrombosis.

scientific article published on 19 January 2016

Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values

scientific article published on 01 January 2019

Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.

scientific article

Rivaroxaban for post-discharge thromboprophylaxis: the MARINER trial

scientific article published on 01 December 2018

Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition

scientific article published on 23 October 2019

Sulodexide for the extended treatment of venous thromboembolism

scientific article

Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury

scientific article

Vascular flow of the gastric fundus after arterial devascularization: an experimental study.

scientific article published on 7 May 2008

Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment.

scientific article published in August 2006

Venous Thromboembolism Prophylaxis and Clinical Consequences in Medically Ill Patients

scientific article published on March 1, 2013

Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis

scientific article published on 24 July 2015